StageZero Life Sciences Ltd.

SZLSFOTCHealthcare● Active

$0.01

+$0.00(+0.00%)

Market Cap$630018

P/E Ratio—

52W High$0.03109

52W Low$0.0005

Avg Volume17

Open$0.01

Beta0.34

Overview

StageZero Life Sciences Ltd. (SZLSF) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

SZLSF · cash on hand · updated Dec 31, 2022

Core cash position

as of Dec 31, 2022

Cash & Short-Term Investments (CCE + ST Investments)

$15,684▼ -99.1% vs prior year

FY · as of Dec 31, 2022 · Reported in USD

Cash & Cash Equiv. (CCE)

$15,684

cashAndCashEquivalents

Short-Term Investments

shortTermInvestments

YoY Change vs Prior Year

-99.1%

vs prior fiscal year

Latest Quarter

$15,032

Q3 2024

Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in USD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: December 31, 2022

Net cash vs debt

Cash vs Debt · Balance Sheet Health

Cash & ST Investments$15,684Cash on Hand

Total Debt$1.8MTotal Debt

Net Cash / Net Debt−$1.8MNet Debt Position

Cash vs Debt Ratio

Cash 1%StageZero Life Sciences Ltd. cash as % of market cap: 2.49%% · MCap $0BDebt 99%

StageZero Life Sciences Ltd. carries a net debt position of $1.8M. Total debt ($1.8M) exceeds cash on hand ($15,684). StageZero Life Sciences Ltd. cash vs debt ratio: 1% cash / 99% debt.

Net Cash = Cash & ST Investments − Total Debt$15,684 − $1.8M = −$1.8M

Cash on hand history

annual cash on hand trend · Cash & Short-Term Investments

YoY Increase

YoY Decrease

Latest Year

SZLSF annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

SZLSF cash & short-term investments history

DatePeriodCash & ST InvestmentsYoY Change

Dec 31, 2022LatestFY$0.0M-99.1%

Dec 31, 2021FY$1.7M-73.9%

Dec 31, 2020FY$6.6M+9175.6%

Dec 31, 2019FY$0.1M-33.0%

Dec 31, 2018FY$0.1M+157.7%

SZLSF cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

SZLSF vs peers · cash on hand

#CompanyCash & ST Inv.Market CapCash/MCapRelative

UnitedHealth Group Incorporated

Eli Lilly and Company

StageZero Life Sciences Ltd.YOU

SZLSF

$0.0M$1M2.5%

Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

StageZero Life Sciences Ltd. (SZLSF) cash on hand as of December 31, 2022 is $15,684, comprising $15,684 in cash and cash equivalents (CCE) plus $0 in short-term investments — reported as StageZero Life Sciences Ltd. cash and short-term investments on the balance sheet (10-K filing). Also referred to as StageZero Life Sciences Ltd. cash reserves or cash position.

StageZero Life Sciences Ltd. annual cash on hand history shows decreased -99.1% in 2022: decreased -99.1% in 2022. StageZero Life Sciences Ltd. cash reserves in 2022 reflect the company's capital allocation strategy.

StageZero Life Sciences Ltd. carries total debt of $1.8M against cash of $15,684, resulting in a net debt position of -$1.8M. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.

Financial statements Free cash flow Net income Revenue Market cap P/E ratio Earnings Price history

Frequently asked questions

SZLSF cash on hand · 5 questions

As of December 31, 2022, StageZero Life Sciences Ltd. (SZLSF) has $15,684 in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $15,684 in cash and cash equivalents (CCE) plus $0 in short-term investments. Latest quarter (September 30, 2024): $15,032. Data sourced from the annual 10-K filing via FMP.

SZLSF cash on handSZLSF cash reservesSZLSF cash 2022how much cash does SZLSF have

▸ Source: FMP /balance-sheet-statement · US GAAP · StageZero Life Sciences Ltd. · StageZero Life Sciences Ltd. SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2022